USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway
- 15 February 2017
- journal article
- research article
- Published by Spandidos Publications in Oncology Reports
- Vol. 37 (4) , 2398-2404
Abstract
In the present study, we first examined the expression of USP39 protein using tissue array containing 90 colorectal cancer (CRC) tissues and 9 clinical samples, and observed that it has significantly higher expression in cancer tissues as compared to the corresponding adjacent normal tissues. Also, we tested USP39 expression level in four CRC cancer cell lines and identified that it indeed had higher expression in all these CRC cell lines. In addition, its knockdown inhibited not only the cell growth of SW480 and HT29 cells, but also the cell migration and invasion. Further analysis of its molecular mechanism suggested that the expression of four crucial proteins of Wnt/β-catenin pathway, including β-catenin, TCF4, MMP2 and MMP9 was reduced as a result of USP39 knockdown. Taken together, all these findings demonstrated that USP39 protein plays an important role in the growth and metastasis of colorectal cancer mainly through Wnt/β-catenin pathway.Keywords
This publication has 29 references indexed in Scilit:
- Aberrant Alternative Splicing Is Another Hallmark of CancerInternational Journal of Cell Biology, 2013
- Caudatin induces cell apoptosis in gastric cancer cells through modulation of Wnt/β-catenin signalingOncology Reports, 2013
- Wnt/β-catenin signalling: from plasma membrane to nucleusBiochemical Journal, 2013
- β‐catenin as a potential key target for tumor suppressionInternational Journal of Cancer, 2011
- Zebrafish usp39 Mutation Leads to rb1 mRNA Splicing Defect and Pituitary Lineage ExpansionPLOS Genetics, 2011
- Regulation and Cellular Roles of Ubiquitin-Specific Deubiquitinating EnzymesAnnual Review of Biochemistry, 2009
- Usp39 is essential for mitotic spindle checkpoint integrity and controls mRNA-levels of Aurora BCell Cycle, 2008
- Wnt Signaling Induces Matrix Metalloproteinase Expression and Regulates T Cell TransmigrationImmunity, 2007
- The Continuum of Care: A Paradigm for the Management of Metastatic Colorectal CancerThe Oncologist, 2007
- Use of plasma MMP‐2 and MMP‐9 levels as a surrogate for tumour expression in colorectal cancer patientsInternational Journal of Cancer, 2003